510(k) K030102
K030102 is an FDA 510(k) premarket notification submitted by Bayer Healthcare, LLC for the device "ADVIA CENTAUR AND ACS:180 LIQUID CARDIAC MARKERS 1, 2, 3". The FDA issued a decision of Substantially Equivalent on January 24, 2003. The device falls under product code JJT (Enzyme Controls (Assayed And Unassayed)), a Class I device regulated under 21 CFR 862.1660. Bayer Healthcare, LLC has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- January 24, 2003
- Date Received
- January 10, 2003
- Clearance Type
- Abbreviated
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Enzyme Controls (Assayed And Unassayed)
- Device Class
- Class I
- Regulation Number
- 862.1660
- Review Panel
- CH
- Submission Type